Changes are happening - please bear with us while we update our site.

Changes are happening - please bear with us while we update our site. Click here to give us your advice and feedback.

All You Want To Know About Estia Health Ltd’s (EHE) Result

Estia Health Ltd (ASX:EHE) today released its 1H FY19 results and its share price is down 2%, so is it a buy?

Estia Health Ltd (ASX: EHE) today released its 1H FY19 results and its share price is down 2%, so is it a buy

Estia Health is one of the largest residential aged care providers in Australia. Estia has 68 homes with 6,046 operational beds across the east coast of Australia and also in South Australia. Estia has reported a bed occupancy rate of 93.9% for 1H FY19, which is down 0.1% for the same corresponding period last year.

The Key Financial Results

Estia Health Ltd announced a fully franked dividend of 8 cents per share, which amounts to a dividend yield of 3.31%.

Operational EBITDA grew by only 3.1% to $46.9 million (click here to learn what EBITDA means). Estia noted that occupancy rates and sector compliance pressures have impacted financial performance. While occupancy rates are projected to rise in the future with the ageing population it is the compliance pressures that should be of concern to investors.

Another financial challenge Estia has faced this year is a decrease in payments of upfront refundable accommodation deposits (RAD) paid by residents. Instead, residents are choosing to pay a partial RAD in combination with a daily accommodation payment (DAP).

Estia states that the RAD decrease has affected facilities in areas where residential house prices have fallen. This change in preferred accommodation payment leaves Estia with less capital available for future investment.

Estia Management Comments

Commenting on the outlook for FY19 and beyond, Estia Chief Executive Officer Ian Thorley said:

“Estia now expects to deliver low to mid-single digit percentage increase on FY18 EBITDA from the existing portfolio of homes in FY19 subject to no further material changes in market or regulatory conditions.”

Is Estia A Buy?

The comments from Estia CEO, Ian Thorley, do not paint a good picture for the near term outlook of the company.

With the Aged Care Royal Commission currently underway, it is highly likely there will be regulatory changes to this sector in the near future. In conjunction with the forecast growth of a low to mid-single-digit percentage increase, I would recommend looking at other investment opportunities. If you are looking to invest in healthcare there are better options available.

[ls_content_block id=”14947″ para=”paragraphs”]

$50,000 per year in passive income from shares? Yes, please!

With interest rates UP, now could be one of the best times to start earning passive income from a portfolio. Imagine earning 4%, 5% — or more — in dividend passive income from the best shares, LICs, or ETFs… it’s like magic.

So how do the best investors do it?

Chief Investment Officer Owen Rask has just released his brand new passive income report. Owen has outlined 10 of his favourite ETFs and shares to watch, his rules for passive income investing, why he would buy ETFs before LICs and more.

You can INSTANTLY access Owen’s report for FREE by CLICKING HERE NOW and creating a 100% FREE Rask Account.

(Psst. By creating a free Rask account, you’ll also get access to 15+ online courses, 1,000+ podcasts, invites to events, a weekly value investing newsletter and more!)

Unsubscribe anytime. Read our TermsFinancial Services GuidePrivacy Policy. We’ll never sell your email address. Our company is Australian owned.

Information warning: The information on this website is published by The Rask Group Pty Ltd (ABN: 36 622 810 995) is limited to factual information or (at most) general financial advice only. That means, the information and advice does not take into account your objectives, financial situation or needs. It is not specific to you, your needs, goals or objectives. Because of that, you should consider if the advice is appropriate to you and your needs, before acting on the information. If you don’t know what your needs are, you should consult a trusted and licensed financial adviser who can provide you with personal financial product advice. In addition, you should obtain and read the product disclosure statement (PDS) before making a decision to acquire a financial product. Please read our Terms and Conditions and Financial Services Guide before using this website. The Rask Group Pty Ltd is a Corporate Authorised Representative (#1280930) of AFSL #383169.

Skip to content